PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-58.71M -68.96M -73.32M -57.85M
Depreciation & Amortization
1.14M 1.26M 315K 307K
Stock-Based Compensation
8.87M 12.38M 10.2M 5.34M
Other Working Capital
-4.93M 5.19M -179K 3.93M
Other Non-Cash Items
-997K -5.76M -385K 955K
Deferred Income Tax
n/a n/a n/a 550K
Change in Working Capital
-1.59M 5.43M -568K 4.12M
Operating Cash Flow
-51.28M -55.66M -63.76M -46.57M
Capital Expenditures
-655K -962K -7.98M -1.35M
Cash Acquisitions
n/a n/a -6.62K 2.74M
Purchase of Investments
-148.29M -220.54M -229.2M -256.85M
Sales Maturities Of Investments
202.04M 170.96M 235.81M 114.61M
Other Investing Acitivies
251K n/a 6.62K -2.74M
Investing Cash Flow
53.35M -50.55M -1.37M -143.58M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
313K 456K 958K 2.02M
Financial Cash Flow
313K 35.58M 958K 2.02M
Net Cash Flow
2.35M -70.59M -64.17M -188.13M
Free Cash Flow
-51.94M -56.62M -71.74M -47.92M